Beijing Aosaikang Pharmaceutical Co., Ltd.

SZSE:002755.SZ

8.79 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2023202220212020201920182017201620152014201320122011
Assets:
Current Assets:
Cash & Cash Equivalents 1,047.047772.7141,165.5621,369.0981,187.1291,084.986189.57270.781254.178100.873150.328176.66287.346
Short Term Investments 713.826839.077522.392100100-0-24.5580.355800000
Cash and Short Term Investments 1,760.8731,611.7911,687.9541,469.0981,287.1291,084.986189.57270.781254.178100.873150.328176.66287.346
Net Receivables 245.96357.675613.771,003.8061,110.403767.779506.54342.419382.597408.559306.616330.93256.396
Inventory 167.489141.533141.845168.736226.556180.46834.8735.21139.69438.79387.67761.5566.666
Other Current Assets 12.15927.11843.5215.26910.8339.4370.33-9.851-9.921-12.898-8.994-11.306-9.561
Total Current Assets 2,186.4812,138.1172,487.092,646.912,634.9172,072.67731.311638.56666.548535.327535.627557.836400.848
Non-Current Assets:
Property, Plant & Equipment, Net 478.396547.142658.332706.658772.919743.90339.90435.04935.35937.60240.38741.65941.022
Goodwill 00000037.898000000
Intangible Assets 628.753511.575406.524319.484169.69284.89412.33453.1240.7240.7491.1941.418
Goodwill and Intangible Assets 628.753511.575406.524319.484169.69284.89450.23153.1240.7240.7491.1941.418
Long Term Investments -595.616-731.509-417.216-22.643-45.886.04329.5290.123.388004.6820
Tax Assets 25.7325.85428.69326.90442.17131.07315.56411.69511.0959.0035.2054.0962.862
Other Non-Current Assets 800.137923.189561.327130.787118.27719.6710.0340.149-3.09100-4.6470.07
Total Non-Current Assets 1,337.41,276.2511,237.661,161.191,057.18885.585135.26352.01449.87647.32946.34146.98545.372
Total Assets 3,523.8823,414.3673,724.753,808.0993,692.0972,958.255866.574690.575716.424582.656581.969604.822446.22
Liabilities & Equity:
Current Liabilities:
Account Payables 38.29339.07765.7295.292275.388136.441143.275102.298122.128164.311168.691176.451104.243
Short Term Debt 117.04748.4872.60720.0130.5544.08510.9233400000
Tax Payables 13.54114.76452.83274.00150.01335.36833.00412.83422.04526.27117.47518.79411.364
Deferred Revenue 272.45211.684331.4570.63155.27235.36819.94838.626-400000
Other Current Liabilities 3.754224.4941.9834.053747.508865.043103.67137.24785.9584.733105.77129.457127.144
Total Current Liabilities 431.545323.743401.71689.9891,078.7221,040.938277.817181.171208.078249.044274.461305.909231.387
Non-Current Liabilities:
Long Term Debt 6.7548.91811.52113.74600015150000
Deferred Revenue Non-Current 64.7255.80868.93169.4160.21248.56346.509000000
Deferred Tax Liabilities Non-Current 10.1812.55915.08215.49236.59127.7683.731000000
Other Non-Current Liabilities 000-13.74600-46.50943.05838.1650035.5260
Total Non-Current Liabilities 81.65477.28595.53484.90296.80376.333.73158.05853.1650035.5260
Total Liabilities 513.199401.028497.244774.8911,175.5251,117.268281.548181.171208.078249.044274.461341.435231.387
Equity:
Preferred Stock 0000000000000
Common Stock 928.16928.16928.16928.16928.16928.16101.34101.34101.3476767676
Retained Earnings 1,580.0791,728.6082,047.251,852.9741,335.544702.513246.532236.998236.747227.012204.124165.011121.952
Accumulated Other Comprehensive Income/Loss 6.579258.58245.438246.866250.876207.545276.29230.787170.2590000
Other Total Stockholders Equity 385.16747.621-2.166-0.849-1.0320-104.981140.278030.627.38422.37616.881
Total Shareholders Equity 2,899.9852,962.973,218.6823,027.1512,513.5481,838.218519.183509.404508.346333.612307.508263.387214.833
Total Equity 3,010.6823,013.3393,227.5063,033.2082,516.5721,840.986585.026511.8510.62333.612307.508263.387214.833
Total Liabilities & Shareholders Equity 3,523.8823,414.3673,724.753,808.0993,692.0972,958.255866.574690.575716.424582.656581.969604.822446.22